Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

Cited by (1,088)

Items 601–700 of 1,088

1. Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
   Kevin Mullane, Michael J. Williams · 2020 · Biochemical Pharmacology
2. Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD)
   on behalf of the JPSFC-AD Study Group, Toshiharu Ninomiya, Shigeyuki Nakaji, Tetsuya Maeda, Masahito Yamada, Masaru Mimura, Kenji Nakashima, Takaaki Mori, Minoru Takebayashi, Tomoyuki Ohara et al. · 2020 · Environmental Health and Preventive Medicine
3. Whole-genome sequencing reveals new Alzheimer’s disease–associated rare variants in loci related to synaptic function and neuronal development
   Prokopenko, Dmitry, Morgan, Sarah L., Mullin, Kristina, Hofmann, Oliver, Chapman, Brad, Kirchner, Rory, Alzheimer's Disease Neuroimaging Initiative (ADNI), Amberkar, Sandeep, Wohlers, Inken, Lange, Christoph et al. · 2021 · Alzheimer's & Dementia
4. Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer’s disease
   Gabrielli, Martina, Prada, Ilaria, Joshi, Pooja, Falcicchia, Chiara, D’Arrigo, Giulia, Rutigliano, Grazia, Battocchio, Elisabetta, Zenatelli, Rossella, Tozzi, Francesca, Radeghieri, Annalisa et al. · 2022 · Brain
5. Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease
   Hui Wang, Jingyun Yang, Julie A. Schneider, Philip L. De Jager, David A. A Bennett, Hongyu Zhang · 2020 · Neurobiology of Aging
6. INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia
   Tsai, Andy P., Lin, Peter Bor-Chian, Dong, Chuanpeng, Moutinho, Miguel, Casali, Brad T., Liu, Yunlong, Lamb, Bruce T., Landreth, Gary E., Oblak, Adrian L., Nho, Kwangsik · 2021 · Neurobiology of Disease
7. PICALM and Alzheimer’s Disease: An Update and Perspectives
   Ando, Kunie, Nagaraj, Siranjeevi, Küçükali, Fahri, de Fisenne, Marie-Ange, Kosa, Andreea-Claudia, Doeraene, Emilie, Lopez Gutierrez, Lidia, Brion, Jean-Pierre, Leroy, Karelle · 2022 · Cells
8. Microglial Metabolic Reprogramming: Emerging Insights and Therapeutic Strategies in Neurodegenerative Diseases
   Jifei Miao, Lihua Chen, Xiaojin Pan, Li-qing Li, Beibei Zhao, Jiao Xia Lan · 2023 · Cellular and Molecular Neurobiology
9. Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
   M. F. Uchoa, V. Moser, Christian J. Pike · 2016 · Frontiers in neuroendocrinology (Print)
10. High resolution genetic mapping of putative causal interactions between regions of open chromatin
    N. Kumasaka, A. Knights, D. Gaffney · 2018 · Nature Genetics
11. Machine Learning Applied to Diagnosis of Human Diseases: A Systematic Review
    Nuria Caballé, José L. Castillo, Juan Antonio Gomez-Pulido, Jose Manuel Gomez-Pulido, María-Luz Polo-Luque · 2020 · Applied Sciences
12. Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
    Jade de Oliveira, Ewa Kucharska, Michelle Lima Garcez, Matheus Scarpatto Rodrigues, João Quevedo, Inés Moreno‐González, Josiane Budni · 2021 · Cells
13. Restoring Oat Nanoparticles Mediated Brain Memory Function of Mice Fed Alcohol by Sorting Inflammatory Dectin‐1 Complex Into Microglial Exosomes
    Fangyi Xu, Jingyao Mu, Yun Teng, Xiangcheng Zhang, Kumaran Sundaram, Mukesh K. Sriwastva, Anil Kumar, Chao Lei, Lifeng Zhang, Qiaohong M. Liu et al. · 2021 · Small
14. Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease
    Jaclyn M. Eissman, Logan C. Dumitrescu, Emily R. Mahoney, Alexandra N. Smith, Shubhabrata Mukherjee, Michael L. Lee, Phoebe Scollard, Seo Eun Choi, William S. Bush, Corinne D. Engelman et al. · 2022 · Brain
15. Alzheimer's disease pathophysiology in the Retina
    Bhakta Prasad Gaire, Yosef Koronyo, Dieu-Trang S. Fuchs, Haoshen Shi, Altan Rentsendorj, Ron Danziger, Jean‐Philippe Vit, Nazanin Mirzaei, Jonah Doustar, Julia Sheyn et al. · 2024 · Progress in Retinal and Eye Research
16. Phenotype-Specific Enrichment of Mendelian Disorder Genes near GWAS Regions across 62 Complex Traits
    Freund, Malika Kumar, Burch, Kathryn S., Shi, Huwenbo, Mancuso, Nicholas, Kichaev, Gleb, Garske, Kristina M., Pan, David Z., Miao, Zong, Mohlke, Karen L., Laakso, Markku et al. · 2018 · The American Journal of Human Genetics
17. Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1-42) in mice
    Garcez, Michelle Lima, Mina, Francielle, Bellettini-Santos, Tatiani, Carneiro, Franciellen Gonçalves, Luz, Aline Pereira, Schiavo, Gustavo Luis, Andrighetti, Matheus Scopel, Scheid, Maylton Grégori, Bolfe, Renan Pereira, Budni, Josiane · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
18. Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
    Takashi Amemori, Pavla Jendelová, Jiří Růžička, Lucia Machová Urdzíková, Eva Syková · 2015 · International Journal of Molecular Sciences
19. Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration
    Wilkins, Heather M., Weidling, Ian W., Ji, Yan, Swerdlow, Russell H. · 2017 · Frontiers in Immunology
20. Women's brain aging: Effects of sex‐hormone exposure, pregnancies, and genetic risk for Alzheimer's disease
    Ann‐Marie G. de Lange, Cláudia Barth, Tobias Kaufmann, Ivan I. Maximov, Dennis van der Meer, Ingrid Agartz, Lars Tjelta Westlye · 2020 · Human Brain Mapping
21. Differential transcript usage unravels gene expression alterations in Alzheimer’s disease human brains
    Diego Marques Coelho, Lukas da Cruz Carvalho Iohan, Ana Raquel Melo de Farias, Amandine Flaig, The Brainbank Neuro–CEB Neuropathology Network, Franck Letournel, Marie‐Laure Martin‐Négrier, Françoise Chapon, Maxime Faisant, Catherine Godfraind et al. · 2021 · npj Aging and Mechanisms of Disease
22. Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
    Martin Barák, Veronika Fedorová, Veronika Pospíšilová, Jan Raška, Simona Vochyánová, Jiří Sedmík, Hana Hříbková, Hana Klímová, Tereza Váňová, Dáša Bohačiaková · 2022 · Stem Cell Reviews and Reports
23. Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
    Lacour, A, Espinosa, A, Louwersheimer, E, Heilmann, S, Hernández, I, Wolfsgruber, S, Fernández, V, Wagner, H, Rosende-Roca, M, Mauleón, A et al. · 2017 · Molecular Psychiatry
24. Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
    López González, Irene, Garcia-Esparcia, Paula, Llorens, Franc, Ferrer, Isidre · 2016 · International Journal of Molecular Sciences
25. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer’s disease
    Tatsuo Mano, Kenichi Nagata, Takashi Nonaka, Airi Tarutani, Tomohiro Imamura, Tadafumi Hashimoto, Taro Bannai, Kagari Koshi Mano, Takeyuki Tsuchida, Ryo Ohtomo et al. · 2017 · Proceedings of the National Academy of Sciences
26. Identification of Differentially Expressed Genes through Integrated Study of Alzheimer’s Disease Affected Brain Regions
    Nisha Puthiyedth, Carlos Riveros, Regina Esther Berretta, Pablo Moscato · 2016 · PLoS ONE
27. Effects of 3D culturing conditions on the transcriptomic profile of stem-cell-derived neurons
    Halil Tekin, Sean Simmons, Beryl B. Cummings, Linyi Alex Gao, Xian Adiconis, Cynthia C. Hession, Ayan Ghoshal, Danielle Ashley Dionne, Sourav Choudhury, Volkan Yesilyurt et al. · 2018 · Nature Biomedical Engineering
28. DNA Nanotweezers and Graphene Transistor Enable Label‐Free Genotyping
    Michael Taeyoung Hwang, Zejun Wang, Jinglei Ping, Deependra Kumar Ban, Zi Chao Shiah, Leif Antonschmidt, Joon Lee, Yushuang Liu, Abhijith G. Karkisaval, Alan T. Charlie Johnson et al. · 2018 · Advanced Materials
29. Relative risk for Alzheimer disease based on complete family history
    Lisa Cannon‐Albright, Norman L. Foster, Karen Cecilia Schliep, James M. Farnham, Craig Carl Teerlink, Heydon K. Kaddas, JoAnn T. Tschanz, Chris Corcoran, John S. K. Kauwe · 2019 · Neurology
30. Genetic instrumental variable regression: Explaining socioeconomic and health outcomes in nonexperimental data
    Thomas Albert DiPrete, Casper A.P. Burik, Philipp Koellinger · 2018 · Proceedings of the National Academy of Sciences
31. Signalling, sorting and scaffolding adaptors for Toll-like receptors
    Lin Luo, Richard M. Lucas, Liping Liu, Jennifer Lea Stow · 2019 · Journal of Cell Science
32. Single-cell eQTL analysis of activated T cell subsets reveals activation and cell type–dependent effects of disease-risk variants
    Benjamin Joachim Schmiedel, Cristian González-Colín, Vicente Fajardo, Job Rocha, Ariel Madrigal, Ciro Ramírez-Suástegui, Sourya Bhattacharyya, Hayley A. Simon, Jason Greenbaum, Bjoern Peters et al. · 2022 · Science Immunology
33. Toward precision medicine in Alzheimer’s disease
    Reitz, Christiane · 2016 · Annals of Translational Medicine
34. Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer’s disease
    Varvel, Nicholas H., Grathwohl, Stefan A., Degenhardt, Karoline, Resch, Claudia, Bosch, Andrea, Jucker, Mathias, Neher, Jonas J. · 2015 · Journal of Experimental Medicine
35. <i>ABCA7</i> frameshift deletion associated with Alzheimer disease in African Americans
    Cukier, Holly N., Kunkle, Brian W., Vardarajan, Badri N., Rolati, Sophie, Hamilton-Nelson, Kara L., Kohli, Martin A., Whitehead, Patrice L., Dombroski, Beth A., Van Booven, Derek, Lang, Rosalyn et al. · 2016 · Neurology Genetics
36. Genome-wide association study of antisocial personality disorder
    M-R Rautiainen, Tiina Paunio, Eila Repo‐Tiihonen, Matti E. Virkkunen, Hanna Maria Ollila, Sonja Sulkava, Otto Jolanki, Aarno V. Palotie, Jari Tiihonen · 2016 · Translational Psychiatry
37. Alcohol and Alzheimer's Disease—Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?
    Ashwin V. Venkataraman, Nicola J. Kalk, Gavin W. Sewell, Craig William Ritchie, Anne R. Lingford-Hughes · 2016 · Alcohol and Alcoholism
38. Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
    Lynn M. Bekris, Maria Khrestian, Eric D. Dyne, Yvonne Y. Shao, Jagan A. Pillai, Stephen M. Rao, Shane M. Bemiller, Bruce T. Lamb, Hubert H. Fernandez, James B. Leverenz · 2018 · Journal of Neuroimmunology
39. A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles
    Jian-Guo Li, Jin Chiu, Mercy M. Ramanjulu, Benjamin E. Blass, Domenico Praticò · 2020 · Molecular Neurodegeneration
40. Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer’s disease
    Tracy L. Young‐Pearse, Hyo Lee, Yi‐Chen Hsieh, Vicky Chou, Dennis J. Selkoe · 2023 · Trends in Neurosciences
41. Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers
    Logan Brase, Shih‐Feng You, Ricardo D’Oliveira Albanus, Jorge L. Del‐Aguila, Yaoyi Dai, Brenna C. Novotny, Carolina Soriano‐Tárraga, Taitea Dykstra, María Victoria Fernández, John Budde et al. · 2023 · Nature Communications
42. Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience
    for the Alzheimer’s Disease Neuroimaging Initiative, Ridge, Perry G., Karch, Celeste M., Hsu, Simon, Arano, Ivan, Teerlink, Craig C., Ebbert, Mark T. W., Gonzalez Murcia, Josue D., Farnham, James M., Damato, Anna R. et al. · 2017 · Genome Medicine
43. Association of Alzheimer's disease GWAS loci with MRI markers of brain aging
    Ganesh Chauhan, Hieab H.H. Adams, Joshua C. Bis, Galit Weinstein, Lei Yu, Anna Maria Töglhofer, Albert V. Smith, Sven J. van der Lee, Rebecca F. Gottesman, Russell J. Thomson et al. · 2015 · Neurobiology of Aging
44. Multimodal Brain Imaging Reveals Structural Differences in Alzheimer’s Disease Polygenic Risk Carriers: A Study in Healthy Young Adults
    Sonya F. Foley, Katherine E. Tansey, Xavier Caseras, Thomas Matthew Lancaster, Tobias Bracht, Greg D. Parker, Jérémy Hall, Julie H. Williams, David E.J. Linden · 2016 · Biological Psychiatry
45. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer’s disease
    Jasmeet Pannu Hayes, Mark W. Logue, Naomi Sadeh, Jeffrey M. Spielberg, Mieke H. Verfaellie, Scott M. Hayes, Andrew Reagan, David H. Salat, Erika J. Wolf, Regina E. McGlinchey et al. · 2017 · Brain
46. Transformation of Summary Statistics from Linear Mixed Model Association on All-or-None Traits to Odds Ratio
    Luke R. Lloyd‐Jones, Matthew R. Robinson, Jian Yang, Peter M. Visscher · 2018 · Genetics
47. Polygenic hazard score: an enrichment marker for Alzheimer’s associated amyloid and tau deposition
    Alzheimer’s Disease Neuroimaging Initiative, Chin Hong Tan, Chun Chieh Fan, Elizabeth C. Mormino, Leo P. Sugrue, Iris Broce, Christopher Paul Hess, William P. Dillon, Luke W. Bonham, Jennifer S. Yokoyama et al. · 2017 · Acta Neuropathologica
48. Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation
    Hariharakrishnan Chidambaram, Rashmi Ranjan Das, Subashchandrabose Chinnathambi · 2020 · Cell & Bioscience
49. Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice
    Knoferle, Johanna, Yoon, Seo Yeon, Walker, David, Leung, Laura, Gillespie, Anna K., Tong, Leslie M., Bien-Ly, Nga, Huang, Yadong · 2014 · The Journal of Neuroscience
50. Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer’s Disease
    Chouraki, Vincent, for the International Genomics of Alzheimer’s Project, Reitz, Christiane, Maury, Fleur, Bis, Joshua C., Bellenguez, Celine, Yu, Lei, Jakobsdottir, Johanna, Mukherjee, Shubhabrata, Adams, Hieab H. et al. · 2016 · Journal of Alzheimer's Disease
51. ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain
    YuHong Fu, Jen-Hsiang T. Hsiao, George Paxinos, Glenda Margaret Halliday, Woojin Scott Kim · 2016 · Journal of Alzheimer s Disease
52. Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene
    Ruiz, A, Heilmann, S, Becker, T, Hernández, I, Wagner, H, Thelen, M, Mauleón, A, Rosende-Roca, M, Bellenguez, C, Bis, J C et al. · 2014 · Translational Psychiatry
53. Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain
    Sottejeau, Yoann, Bretteville, Alexis, Cantrelle, François-Xavier, Malmanche, Nicolas, Demiaute, Florie, Mendes, Tiago, Delay, Charlotte, Alves Dos Alves, Harmony, Flaig, Amandine, Davies, Peter et al. · 2015 · Acta Neuropathologica Communications
54. Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer’s disease
    Lu, Qiongshi, Powles, Ryan L., Abdallah, Sarah, Ou, Derek, Wang, Qian, Hu, Yiming, Lu, Yisi, Liu, Wei, Li, Boyang, Mukherjee, Shubhabrata et al. · 2017 · PLOS Genetics
55. Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease
    Susana López‐Ortiz, José Pinto-Fraga, Pedro L. Valenzuela, Juan Martín-Hernández, María M. Seisdedos, Óscar Garcı́a, Nicola Toschi, Francesca Di Giuliano, Francesco Giuseppe Garaci, Nicola Biagio Mercuri et al. · 2021 · International Journal of Molecular Sciences
56. Late-onset Alzheimer’s risk variants in memory decline, incident mild cognitive impairment, and Alzheimer’s disease
    Minerva M. Carrasquillo, Julia E. Crook, Otto Pedraza, Colleen S. Thomas, V. Shane Pankratz, Mariet Allen, Thuy Nguyen, Kimberly G. Malphrus, Li Ma, Gina D. Bisceglio et al. · 2014 · Neurobiology of Aging
57. Genetic variants in Alzheimer disease — molecular and brain network approaches
    Chris Gaiteri, Sara Mostafavi, Christopher John Honey, Philip L. De Jager, David Alan Bennett · 2016 · Nature Reviews Neurology
58. Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans
    Jesse B Mez, Jaeyoon Chung, Gyungah Jun, Joshua Kriegel, Alexandra P. Bourlas, Richard Sherva, Mark W. Logue, Lisa Laverne Barnes, David Alan Bennett, Joseph D. Buxbaum et al. · 2016 · Alzheimer s & Dementia
59. The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
    Hannah R. Stocker, Tobias Möllers, Laura Perna, Hermann Brenner · 2018 · Translational Psychiatry
60. Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease
    Rathore, Nisha, Ramani, Sree Ranjani, Pantua, Homer, Payandeh, Jian, Bhangale, Tushar, Wuster, Arthur, Kapoor, Manav, Sun, Yonglian, Kapadia, Sharookh B., Gonzalez, Lino et al. · 2018 · PLOS Genetics
61. Nutrition, the brain and cognitive decline: insights from epigenetics
    M. J. Dauncey · 2014 · European Journal of Clinical Nutrition
62. Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
    Terzioglu, Gizem, Young-Pearse, Tracy L. · 2023 · Molecular Neurodegeneration
63. BIN1 regulates BACE1 intracellular trafficking and amyloid-β production
    Miyagawa, Toji, Ebinuma, Ihori, Morohashi, Yuichi, Hori, Yukiko, Young Chang, Mee, Hattori, Haruhiko, Maehara, Tomoaki, Yokoshima, Satoshi, Fukuyama, Tohru, Tsuji, Shoji et al. · 2016 · Human Molecular Genetics
64. Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment
    Ali Amidi, Mads Agerbæk, Lisa Maria Wu, Anders Degn Pedersen, Mimi Yung Mehlsen, Cecilie R. Clausen, Ditte Demontis, Anders Dupont Børglum, Anja Harbøll, Robert Hugh Zachariae · 2016 · Brain Imaging and Behavior
65. CXCR4 involvement in neurodegenerative diseases
    Luke W. Bonham, Celeste M M. Karch, Chun Chieh Fan, Chin Hong Tan, Ethan G. Geier, Yunpeng Wang, Natalie Wen, Iris Broce, Yi Li, Matthew J. Barkovich et al. · 2018 · Translational Psychiatry
66. Genetic variation in PLEKHG1 is associated with white matter hyperintensities (n = 11,226)
    Matthew Traylor, Daniel J. Tozer, Iain David Croall, D Ford, Abiodun Olubunmi Olorunda, Giorgio Battista Boncoraglio, Martin Dichgans, Robin Lemmens, Jonathan M. Rosand, Natalia S. Rost et al. · 2019 · Neurology
67. Polygenic risk and hazard scores for Alzheimer's disease prediction
    Ganna Leonenko, Rebecca Sims, Maryam Shoai, Aura Frizzati, Paola Bossù, Gianfranco Spalletta, Nick C. Fox, Julie H. Williams, John Hardy, Valentina Escott‐Price · 2019 · Annals of Clinical and Translational Neurology
68. Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
    Jiansong Fang, Andrew A. Pieper, Ruth Nussinov, Garam Lee, Lynn M. Bekris, James B. Leverenz, Jeffrey L. Cummings, Feixiong Cheng · 2020 · Medicinal Research Reviews
69. Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression
    Zhou, Hang, Polimanti, Renato, Yang, Bao-Zhu, Wang, Qian, Han, Shizhong, Sherva, Richard, Nuñez, Yaira Z., Zhao, Hongyu, Farrer, Lindsay A., Kranzler, Henry R. et al. · 2017 · JAMA Psychiatry
70. Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis
    Zhou, Xiaopu, Chen, Yu, Mok, Kin Y., Zhao, Qianhua, Chen, Keliang, Chen, Yuewen, Hardy, John, Li, Yun, Fu, Amy K. Y., Guo, Qihao et al. · 2018 · Proceedings of the National Academy of Sciences
71. TYROBP genetic variants in early-onset Alzheimer's disease
    Pottier, Cyril, Ravenscroft, Thomas A., Brown, Patricia H., Finch, NiCole A., Baker, Matt, Parsons, Meeia, Asmann, Yan W., Ren, Yingxue, Christopher, Elizabeth, Levitch, Denise et al. · 2016 · Neurobiology of Aging
72. Evaluation of CD33 as a genetic risk factor for Alzheimer’s disease
    Steven Estus, Benjamin C. Shaw, Nicholas A. Devanney, Yuriko Katsumata, Eileen Press, David W. Fardo · 2019 · Acta Neuropathologica
73. Is Alzheimer’s disease an inflammasomopathy?
    Cláudia Pereira, Armanda E. Santos, Paula Isabel Moreira, Ana Catarina Pereira, Fábio J. Sousa, Sandra M. Cardoso, Maria Teresa Cruz · 2019 · Ageing Research Reviews
74. Neuroinflammation: An overview of neurodegenerative and metabolic diseases and of biotechnological studies
    Ana Paula de Araújo Boleti, Taylla Michelle de Oliveira Flores, Susana Elisa Moreno, Lilian Carneiro dos Anjos, Márcia Renata Mortari, Ludovico Migliolo · 2020 · Neurochemistry International
75. Tau Pathology Drives Dementia Risk-Associated Gene Networks toward Chronic Inflammatory States and Immunosuppression
    Rexach, Jessica E., Polioudakis, Damon, Yin, Anna, Swarup, Vivek, Chang, Timothy S., Nguyen, Tam, Sarkar, Arjun, Chen, Lawrence, Huang, Jerry, Lin, Li-Chun et al. · 2020 · Cell Reports
76. Using Mendelian randomization analysis to better understand the relationship between mental health and substance use: a systematic review
    Jorien L. Treur, Marcus Robert Munafo, Emma Logtenberg, Reinout W. H. J. Wiers, Karin J. H. Verweij · 2021 · Psychological Medicine
77. Genomics of Alzheimer’s disease implicates the innate and adaptive immune systems
    Yihan Li, Simon Matthew Laws, Luke A. Miles, James S. Wiley, Xin Huang, Colin Louis Masters, Ben J. Gu · 2021 · Cellular and Molecular Life Sciences
78. An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer’s disease
    On Behalf of the BELNEU Consortium, De Roeck, Arne, Duchateau, Lena, Van Dongen, Jasper, Cacace, Rita, Bjerke, Maria, Van den Bossche, Tobi, Cras, Patrick, Vandenberghe, Rik, De Deyn, Peter P. et al. · 2018 · Acta Neuropathologica
79. EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimerʼns disease
    Tai, Leon M., Balu, Deebika, Avila-Munoz, Evangelina, Abdullah, Laila, Thomas, Riya, Collins, Nicole, Valencia-Olvera, Ana Carolina, LaDu, Mary Jo · 2017 · Journal of Lipid Research
80. GJA1 (connexin43) is a key regulator of Alzheimer’s disease pathogenesis
    Yuji Kajiwara, Erming Wang, Minghui Wang, Wun Chey Sin, Kristen Brennand, Eric E. Schadt, Christian C. G. Naus, Joseph D. Buxbaum, Bin Zhang · 2018 · Acta Neuropathologica Communications
81. Measuring heritable contributions to Alzheimer’s disease: polygenic risk score analysis with twins
    Ida Karlsson, Valentina Escott‐Price, Margaret Gatz, John Hardy, Nancy L. Pedersen, Maryam Shoai, Chandra A. Reynolds · 2021 · Brain Communications
82. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology
    Peter T. Nelson, Steven Estus, Erin L. Abner, Ishita J. Parikh, Manasi Malik, Janna H. Neltner, Eseosa T. Ighodaro, Wang‐Xia Wang, Bernard R. Wilfred, Li‐San Wang et al. · 2014 · Acta Neuropathologica
83. Emerging roles for MEF2 in brain development and mental disorders
    Assali, Ahlem, Harrington, Adam J, Cowan, Christopher W · 2019 · Current Opinion in Neurobiology
84. The Evolution of Genetics: Alzheimer’s and Parkinson’s Diseases
    Andrew Singleton, John Hardy · 2016 · Neuron
85. Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
    Rosie May Walker, Kadi Vaher, Mairead L. Bermingham, Stewart W. Morris, Andrew D. Bretherick, Yanni Zeng, Konrad Rawlik, Carmen Amador, Archie Campbell, Chris Haley et al. · 2021 · Genome Medicine
86. Deciphering the Molecular Profile of Plaques, Memory Decline and Neuron Loss in Two Mouse Models for Alzheimer’s Disease by Deep Sequencing
    Yvonne Bouter, Tim Kacprowski, Robert Weißmann, Katharina Dietrich, Henning Borgers, A Brauß, Christian Sperling, Oliver Wirths, Mario Albrecht, Lars R. Jensen et al. · 2014 · Frontiers in Aging Neuroscience
87. Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease
    Lambert, Jean-Charles, Ramirez, Alfredo, Grenier-Boley, Benjamin, Bellenguez, Céline · 2023 · Molecular Psychiatry
88. Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case–control study
    Steele, Natasha Z. R., Carr, Jessie S., Bonham, Luke W., Geier, Ethan G., Damotte, Vincent, Miller, Zachary A., Desikan, Rahul S., Boehme, Kevin L., Mukherjee, Shubhabrata, Crane, Paul K. et al. · 2017 · PLOS Medicine
89. Absolute 10-year risk of dementia by age, sex and <i>APOE</i> genotype: a population-based cohort study
    Rasmussen, Katrine L., Tybjærg-Hansen, Anne, Nordestgaard, Børge G., Frikke-Schmidt, Ruth · 2018 · Canadian Medical Association Journal
90. MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice
    Amanda Mitchell, Behnam Javidfar, Venu Pothula, Daisuke Ibi, Erica Shen, Cyril Jayakumar Peter, Lucy K. Bicks, Tristan Fehr, Yan ping Jiang, Kristen Brennand et al. · 2017 · Molecular Psychiatry
91. Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
    EPAD Study Group, Shubhabrata Mukherjee, Investigators from ACT, Investigators from ROS, Investigators from MAP, Investigators from ADNI, Jesse B Mez, Emily H. Trittschuh, Andrew J. Saykin, Laura E. Gibbons et al. · 2018 · Molecular Psychiatry
92. The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor
    Dlugosz, Paula, Nimpf, Johannes · 2018 · International Journal of Molecular Sciences
93. Decreased CALM expression reduces Aβ42 to total Aβ ratio through clathrin-mediated endocytosis of γ-secretase
    Kunihiko Kanatsu, Yuichi Morohashi, Mai Suzuki, Hiromasa Kuroda, Toshio Watanabe, Taisuke Tomita, Takeshi Iwatsubo · 2014 · Nature Communications
94. An Overview of Genome-Wide Association Studies in Alzheimer’s Disease
    Luxi Shen, Jianping Jia · 2016 · Neuroscience Bulletin
95. Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer's disease brain
    Adam R. Smith, Rebecca G. Smith, Daniel Condliffe, Eilis J. Hannon, Leonard C. Schalkwyk, Jonathan S. Mill, Katie Lunnon · 2016 · Neurobiology of Aging
96. Dissociable influences of APOE ε4 and polygenic risk of AD dementia on amyloid and cognition
    Tian Ge, Mert Rory Sabuncu, Jordan W. Smoller, Reisa Anne Sperling, Elizabeth C. Mormino, Alzheimer’s Disease Neuroimaging Initiative · 2018 · Neurology
97. Linking mechanisms of periodontitis to Alzheimer's disease
    Mahtab Sadrameli, Praveen Bathini, Lavinia Auber Alberi · 2020 · Current Opinion in Neurology
98. The Effects of Chronic Exposure to Ambient Traffic-Related Air Pollution on Alzheimer’s Disease Phenotypes in Wildtype and Genetically Predisposed Male and Female Rats
    Kelley T. Patten, Anthony E. Valenzuela, Christopher Wallis, Elizabeth L. Berg, Jill L. Silverman, Keith J. Bein, Anthony S. Wexler, Pamela J. Lein · 2021 · Environmental Health Perspectives
99. The emerging tale of microglia in psychiatric disorders
    Reza Rahimian, Marina Wakid, Liam Anuj O’Leary, Naguib Mechawar · 2021 · Neuroscience & Biobehavioral Reviews
100. Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia
     Hieab H.H. Adams, Renée F.A.G. de Bruijn, Albert Hofman D, André Gerardus Uitterlinden, Cornelia M. van Duijn, Meike Willemijn Vernooij, Peter J. Koudstaal, M. Arfan Ikram · 2015 · Alzheimer s & Dementia